Skip to main content

Balance Labs Inc

For the period ended Dec 31, 2023. Filed Apr 15, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Apr 15, 2024

BLNCStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 15. Exhibits, Financial Statement Schedules

1.Consolidated Financial Statements

The financial statements are included in Item 8. “Consolidated Financial Statements and Supplementary Data.”

2.Consolidated Financial Statement Schedules

All schedules are omitted as information required is inapplicable or the information is presented in the consolidated financial statements and the related notes.

3.Exhibits

The following is a list of exhibits filed with this Annual Report incorporated herein by reference (numbered in accordance with Item 601 of Regulation S-K):

Exhibit No.Title
3.1Certificate of Incorporation (1)
3.2By-laws (1)
4.210% Convertible Debenture by and between the Company and Newel dated April 1, 2016 (3)
4.3Warrant to Purchase Common Stock by and between the Company and Newel dated April 1, 2016 (3)
4.4Description of Securities (6)
4.5Convertible Promissory Note dated June 28, 2021 (5)
10.1Consulting Agreement between Michael Farkas and the Company dated February 6, 2015 (1)
10.2Service Agreement between Bang Holdings Corp. and the Company dated August 22, 2014 (1)
10.3Form of Securities Purchase Agreement dated September 17, 2015, by and between Balance Labs, Inc. and certain investors (2)
10.4Investment Agreement by and between the Company and Newel dated April 1, 2016 (3)
10.5Registration Rights Agreement by and between the Company and Newel dated April 1, 2016 (3)
10.6Promissory Note between Four Acquisitions Tech LTD and Balance Labs, Inc. dated September 30, 2021 (6)
10.7Promissory Note between Four Acquisitions Tech Ltd. and Balance Labs, Inc. dated January 29, 2021 (6)
10.8Form of Promissory note (6)
21.1Subsidiaries (4)
31.1Certification of principal executive officer pursuant to Section 3.02 of the Sarbanes-Oxley Act of 2002*
31.2Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1Certification of principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
32.2Certification of principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
97.1Balance Labs, Inc. Clawback Policy*
101.INSInline XBRL Instance Document*
101.SCHInline XBRL Taxonomy Extension Schema Document*
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document*
101.LABInline XBRL Taxonomy Extension Label Linkbase Document*
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document*
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document*
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
*Filed herewith
**Furnished herewith
(1)Incorporated by reference to the Registration Statement on Form S-1 filed with the SEC on March 24, 2015.
(2)Incorporated by reference to the Quarterly Report on Form 10-Q filed with the SEC on November 16, 2015.
(3)Incorporated by reference to the Current Report on Form 8-K filed with the SEC on April 8, 2016.
(5)Incorporated by reference to the Quarterly Report on Form 10-Q filed with the SEC on November 19, 2021.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.